By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Martinstrasse 10-12

Aachen    52062  Germany
Phone: 49-241-4453-0 Fax: 49-241-4453-100


Company News
PAION AG: Positive Remimazolam Phase III Colonoscopy Results Presented At The 2016 American College of Gastroenterology Annual Scientific Meeting 10/19/2016 11:19:25 AM
PAION AG Announces Initiation Of U.S. Phase 3 Clinical Trial Of Remimazolam For Procedural Sedation During Colonoscopy 3/31/2015 6:07:13 AM
PAION AG Release: Recruitment of Phase II/III Study With Short-Acting Anaesthetic/Sedative Remimazolam (Ono's Development Code: ONO-2745) in Japan is Completed 5/8/2013 9:57:37 AM
PAION Announces Patient Recruitment for Phase IIa Study with its Short Acting Anesthetic/Sedative CNS 7056 Successfully Completed 9/8/2009 10:21:25 AM
PAION to Present at Five Upcoming Conferences 9/8/2009 9:20:57 AM
PAION Reports Results for the First Half Year 2009 8/5/2009 9:52:15 AM
Financial News: PAION: Announcement according to Articles 37v-x et seqq. of the WpHG [German Securities Trading Act] with the objective of Europe-wide Distribution 7/29/2009 9:06:20 AM
PAION: Phase Ib and IIa Studies of the Anesthetic/Sedative CNS 7056 on Track 7/15/2009 9:19:49 AM
PAION Reports Results for the First Quarter 2009 5/13/2009 10:02:49 AM
PAION Completes First Part of Phase Ib Study of the Anesthetic/Sedative CNS 7056 5/11/2009 10:39:54 AM